Clean Science & Technology Ltd. · NSE:CLEAN
Clean Science & Technology — Q4 FY2023 Earnings Presentation
21 slides from Clean Science & Technology's earnings presentation, May 18, 2023
Slide 1: Exchange filing cover letter for investor presentation
18.05.2023 To, BSE Limited National Stock Exchange of India Limited Phiroze JeeJeebhoy Towers, Exchange Plaza, Plot no. C/1, Dalal Street, G Block, Bandra-Kurla Complex Fort, Mumbai – 400 001 Bandra (E), Scrip Code: 543318 Mumbai - 400 051 Trading Symbol: CLEAN Subject: Investor Presentation. Dear S
Slide 2: Clean Science and Technology Ltd. Investor Presentation Q4 and FY 2023
Clean Science and Technology Ltd. Investor Presentation Q4 and FY 2023 I May 2023
Slide 3: Safe Harbour
SAFE HARBOUR This investor presentation has been prepared by Clean Science and Technology Limited (“CSTL”) and does not constitute a prospectus or placement memorandum or an offer to acquire any securities. This presentation or any other documentation or information (or any part thereof) delivered o
Slide 4: Q4 FY 2023 & FY 2023 Update
Q4 FY 2023 & FY 2023 Update
Slide 5: Q4 FY23 Update
Q4 FY23 UPDATE Steady revenue; moderation in input prices enabled strong improvement in margins Revenue in INR Crore 146 153 181 205 234 248 237 217 Q1 FY22 Q2 FY22 Q3 FY22 Q4 FY22 Q1 FY23 Q2 FY23 Q3 FY23 Q4 FY23 49.3% 49.1% 45.3% 46.1% 42.7% 41.3% 39.4% 39.8% 31.7% 29.9% 29.2% 37.9% 35.5% 35.1% 33.
Slide 6: Q4 FY23 and FY 2023 P&L Overview - Standalone
Q4 FY23 AND FY 2023 P&L OVERVIEW - STANDALONE Crossed milestone of + US $100 million revenue in FY 2023; Highest revenue and profitability for a financial year with stable margins amidst macro challenges P&L (INR Crore) Q4 FY2023 Q3 FY2023 Q-o-Q (%) Q4 FY2022 Y-o-Y (%) FY 2023 FY 2022 Y-o-Y (%) Sale
Slide 7: Revenue Profile – FY 2023
REVENUE PROFILE – FY 2023 Strong revenue growth across all segments and geographies with improved volume offtake and realisations REVENUE MIX BY SEGMENT REVENUE MIX BY GEOGRAPHY 12% 12% 11% 6% 6% 6% 12% 14% 16% 16% 17% 19% 14% 15% 16% 32% 30% 28% 70% 69% 69% 37% 34% 35% FY 2021 FY 2022 FY 2023 FY 20
Slide 8: FY 2023: Debt Free Balance Sheet with Cash Surplus
FY 2023: DEBT FREE BALANCE SHEET WITH CASH SURPLUS OF ~INR 300 CRORES Stable return ratios; Internal accruals to fuel capex plans As at As at In INR Crore 31-March-2023 31-March-2022 Assets Non-current assets Fixed Assets 422.1 292.3 Capital work-in-progress 4.1 44.1 Right of use asset 3.9 2.9 Other
Slide 9: Corporate presentation
Corporate presentation
Slide 10: Clean Science and Technology at a Glance
CLEAN SCIENCE AND TECHNOLOGY AT A GLANCE A brief Introduction about the Company One of the fastest growing and among the most profitable fine and specialty chemical companies globally. Among the largest manufacturers of certain specialty chemicals developed in-house. Among the few global organiz
Slide 11: Company Evolution
COMPANY EVOLUTION Continuous R&D and Innovation has led to new product launches on a consistent basis YEAR 2006 2009 2011 2014 2018 2020 2021 2022 2023 REVENUES (INR Crore) - 1 19 120 241 419 512 685 936 Commercialized plant to 2022 2023 manufacture P-BQ and TBHQ Commercialized unique 2020 Com
Slide 12: Diversified Product Profile Serving Critical End-User Industries
DIVERSIFIED PRODUCT PROFILE SERVING CRITICAL END-USER INDUSTRIES Largest capacity in the world for our flagship products PERFORMANCE PHARMA AND AGRO FMCG CHEMICALS INTERMEDIATES CHEMICALS MEHQ (Monomethyl Ether of Hydroquinone) Guaiacol 4-MAP (4-Methoxy Acetophenone) Used as polymerization inhibit
Slide 13: Key Differentiators That Add Value
KEY DIFFERENTIATORS THAT ADD VALUE Unique benefits that set our business apart from competition INNOVATION GLOBAL LEADERS PREFERRED PARTNER STATE-OF-THE-ART Strategic process innovation Among the largest OF CHOICE Multiple, automated and new product producers globally of Strong and long term manufac
Slide 14: Steadfast Focus on Research & Development
STEADFAST FOCUS ON RESEARCH & DEVELOPMENT Pioneered commercialization of catalytic reactions Research and Development team’s focus areas Enhance our existing catalyst Develop products with high demand Expand product portfolio in the 1 systems to further optimize yield 2 performance chemical segment
Slide 15: Cohesive and Technocrat Promoters
COHESIVE AND TECHNOCRAT PROMOTERS Strong visibility on longevity of Promoters’ engagement in the business Over 27 years of work experience in Over 17 years of experience in the the chemical industry. chemical industry. Previously worked as an Executive Director at Mangalam Drugs and Bachelor of Chem
Slide 16: Robust Corporate Governance
ROBUST CORPORATE GOVERNANCE Distinguished Board of Directors and reputed financial market participants underscore sound governance PROFILE OF NON-EXECUTIVE, INDEPENDENT DIRECTORS ON THE BOARD PRADEEP RATHI PROF. G. D. YADAV Sanjay Kothari Chairman and Non-Executive Director Non-Executive, Independen
Slide 17: Continued Commitment Towards Sustainability and ESG
CONTINUED COMMITMENT TOWARDS SUSTAINABILITY AND ESG Sustainability and ESG initiatives are embedded in our long term growth strategy ENVIRONMENT EMPATHY (E) SOCIAL RESPONSIBILITY (S) CORPORATE GOVERNANCE (G) Utilize resources efficiently, reduce waste Total contribution towards CSR activities
Slide 18: Advanced Manufacturing Facilities Designed by In-House Engineering Team
ADVANCED MANUFACTURING FACILITIES DESIGNED BY IN-HOUSE ENGINEERING TEAM 3 independent functional units at Kurkumbh Industrial Area, Maharashtra with dedicated lines for each product UNIT 1 NO plant closure notice received from pollution 7 plants control board Total area – 30,000 sq.m All Units are I
Slide 19: Strong Financial Performance
STRONG FINANCIAL PERFORMANCE Resilient performance demonstrated over business cycles maintaining a debt free balance sheet REVENUE EBITDA & EBITDA% PAT & PAT% CAGR of 24% EBITDA CAGR of 31% PAT CAGR of 33% 393 419 512 685 936 136 185 259 300 403 98 140 198 229 304 44% 43% 33% 33% 51% 39% 44% 25% 33%
Slide 20: Our Key Growth Drivers
KEY GROWTH LEVERS Strategic initiatives and investments aimed at long term sustainable growth FOCUS ON ESG AND SIGNIFICANT SUSTAINABILITY GREENFIELD CAPEX Capitalise on our core philosophy Planned capex on track for of clean and green chemistry to commercialising new series of address opportunities
Slide 21: Thank You
THANK YOU For further information, please contact: SWAPNIL MORAY Investor Relations Email: swapnil@cleanscience.co.in Clean Science and Technology Limited Website: https://www.cleanscience.co.in/
Clean Science and Technology — Q4 FY2023 Earnings Presentation on 6ix